Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on February 11, 2014. The filing discloses a presentation made by a company representative at the BIO CEO & Investor Conference 2014 held in New York, NY.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a conference presentation and does not contain financial statements or operational data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is limited to the disclosure of the conference presentation under Regulation FD.
Guidance, Outlook, and Risks
The company presented slides at the BIO CEO & Investor Conference, which are attached as Exhibit 99.01. The filing explicitly states that the information contained in the report and exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. No specific guidance, risks, or contingencies are detailed within the text of this 8-K.
Key Facts for Investor Verification
- Verify the content of the presentation slides attached as Exhibit 99.01 for any forward-looking statements or strategic updates.
- Confirm that the registrant is Neuralstem, Inc., as the input metadata referenced Palisade Bio, Inc. incorrectly.
- Note that this filing does not constitute a formal financial update or contain audited financial data.